{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:32:06Z","timestamp":1790555526222,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jclinane.2020.109818","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T23:30:55Z","timestamp":1586907055000},"page":"109818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"64","author":[{"given":"Amit D.","family":"Raval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Uyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Karabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin J.","family":"Brull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jclinane.2020.109818_bb0005","first-page":"527","article-title":"The cultural characters and pathogenicity for some laboratory animals of the vole strain of acid-fast bacillus","volume":"42","author":"Griffith","year":"1942","journal-title":"J Hyg (Lond)"},{"issue":"3","key":"10.1016\/j.jclinane.2020.109818_bb0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1213\/ANE.0000000000000513","article-title":"Game changers: the 20 most important anesthesia articles ever published","volume":"120","author":"Barash","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jclinane.2020.109818_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12688\/f1000research.13169.1","article-title":"Recent advances in neuromuscular block during anesthesia","volume":"7","author":"Boon","year":"2018","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1213\/ANE.0b013e3181da832d","article-title":"Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block","volume":"111","author":"Murphy","year":"2010","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.jclinane.2020.109818_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbr.2014.04.008","article-title":"Adverse respiratory events in a post-anesthesia care unit","volume":"51","author":"Xara","year":"2015","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","article-title":"Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit","volume":"107","author":"Murphy","year":"2008","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.jclinane.2020.109818_bb0035","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/ALN.0000000000000865","article-title":"Residual neuromuscular block in the elderly: incidence and clinical implications","volume":"123","author":"Murphy","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jclinane.2020.109818_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/ALN.0000000000002711","article-title":"Influence of reversal of a partial neuromuscular block on the ventilatory response to hypoxia: a randomized controlled trial in healthy volunteers","volume":"131","author":"Broens","year":"2019","journal-title":"Anesthesiology"},{"issue":"21\u221222","key":"10.1016\/j.jclinane.2020.109818_bb0045","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1111\/jocn.12508","article-title":"Residual neuromuscular blockade and postoperative critical respiratory events: literature review","volume":"23","author":"Kiekkas","year":"2014","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.jclinane.2020.109818_bb0050","series-title":"Prescribing information for BLOXIVERZ (neostigmine methylsulfate injection), for intravenous use","author":"Eclat Pharmaceuticlas L","year":"2013"},{"issue":"8","key":"10.1016\/j.jclinane.2020.109818_bb0055","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jclinane.2020.109818_bb0060","series-title":"ASSESSMENT REPORT FOR Bridion. European medicines agency: Evaluation of medicines for human use","author":"Agency EM","year":"2008"},{"issue":"12","key":"10.1016\/j.jclinane.2020.109818_bb0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/anae.13277","article-title":"A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade","volume":"70","author":"Abad-Gurumeta","year":"2015","journal-title":"Anaesthesia"},{"issue":"39","key":"10.1016\/j.jclinane.2020.109818_bb0070","first-page":"1","article-title":"Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment","volume":"14","author":"Chambers","year":"2010","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"5","key":"10.1016\/j.jclinane.2020.109818_bb0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/bja\/aeq269","article-title":"Sugammadex compared with neostigmine\/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation","volume":"105","author":"Paton","year":"2010","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","article-title":"Consensus statement on perioperative use of neuromuscular monitoring","volume":"127","author":"Naguib","year":"2018","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.jclinane.2020.109818_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ALN.0b013e318182af3b","article-title":"Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit","volume":"109","author":"Murphy","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jclinane.2020.109818_bb0090","unstructured":"Higgins J GS. Cochrane handbook for systematic reviews of interventions Version 5.1.0 (updated March 2011). 2011."},{"key":"10.1016\/j.jclinane.2020.109818_bb0095","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jclinane.2020.109818_bb0100","series-title":"Excellence. NIfHaC. The guidelines manual (PMG6): Tools and resources (Appendix C)","year":"2014"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","article-title":"Current status of neuromuscular reversal and monitoring: challenges and opportunities","volume":"126","author":"Brull","year":"2017","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.jclinane.2020.109818_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der Simonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.jclinane.2020.109818_bb0115","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"10.1016\/j.jclinane.2020.109818_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1016\/j.jclinane.2020.109818_bb0125","series-title":"(sugammadex) injection [prescribing information]","author":"BRIDION\u00ae","year":"2018"},{"issue":"22","key":"10.1016\/j.jclinane.2020.109818_bb0130","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.119.039996","article-title":"Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction","volume":"139","author":"Furtado","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jclinane.2020.109818_bb0135","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1053\/j.jvca.2015.02.014","article-title":"Target-controlled infusion of remifentanil without muscle relaxants allows acceptable surgical conditions during thoracotomy performed under sevoflurane anesthesia","volume":"29","author":"El-Tahan","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"8","key":"10.1016\/j.jclinane.2020.109818_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2044.2011.06782.x","article-title":"Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients","volume":"66","author":"Van Lancker","year":"2011","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.jclinane.2020.109818_bb0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","article-title":"Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine","volume":"109","author":"Jones","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jclinane.2020.109818_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2253-10-15","article-title":"Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine","volume":"10","author":"Lemmens","year":"2010","journal-title":"BMC Anesthesiol"},{"issue":"10","key":"10.1016\/j.jclinane.2020.109818_bb0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/EJA.0b013e32833d56b7","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial","volume":"27","author":"Blobner","year":"2010","journal-title":"Eur J Anaesthesiol"},{"issue":"10","key":"10.1016\/j.jclinane.2020.109818_bb0160","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/anae.13894","article-title":"Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure","volume":"72","author":"Choi","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jclinane.2020.109818_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jclinane.2016.07.031","article-title":"Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial","volume":"35","author":"Feltracco","year":"2016","journal-title":"J Clin Anesth"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1213\/01.ANE.0000095040.36648.F7","article-title":"Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium","volume":"98","author":"Murphy","year":"2004","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.jclinane.2020.109818_bb0175","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00101-015-0048-0","article-title":"Recovery from prolonged deep rocuronium-induced neuromuscular blockade: a randomized comparison of sugammadex reversal with spontaneous recovery","volume":"64","author":"Rahe-Meyer","year":"2015","journal-title":"Anaesthesist"},{"issue":"140","key":"10.1016\/j.jclinane.2020.109818_bb0180","article-title":"Residual neuromuscular blockade at extubation: a randomized comparison of sugammadex and neostigmine reversal of rocuronium-induced blockade in patients undergoing abdominal surgery","volume":"2","author":"Sabo","year":"2011","journal-title":"J Anesthe Clinic Res"},{"issue":"10","key":"10.1016\/j.jclinane.2020.109818_bb0185","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s11695-013-0926-y","article-title":"Sugammadex allows fast-track bariatric surgery","volume":"23","author":"Carron","year":"2013","journal-title":"Obes Surg"},{"issue":"9","key":"10.1016\/j.jclinane.2020.109818_bb0190","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1365-2044.2012.07197.x","article-title":"A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery","volume":"67","author":"Geldner","year":"2012","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1213\/ane.0b013e3181ac53c3","article-title":"Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial","volume":"110","author":"Khuenl-Brady","year":"2010","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.jclinane.2020.109818_bb0200","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/ALN.0b013e31819dabb0","article-title":"Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine","volume":"110","author":"Lee","year":"2009","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.jclinane.2020.109818_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/anae.13344","article-title":"Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients","volume":"71","author":"Loupec","year":"2016","journal-title":"Anaesthesia"},{"issue":"9","key":"10.1016\/j.jclinane.2020.109818_bb0210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/EJA.0000000000000585","article-title":"Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: a partially randomised placebo controlled trial","volume":"34","author":"Nemes","year":"2017","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"10.1016\/j.jclinane.2020.109818_bb0215","first-page":"269","article-title":"Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: a double-blind, randomised study","volume":"35","author":"Preault","year":"2016","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2253-14-53","article-title":"Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"10.1016\/j.jclinane.2020.109818_bb0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1213\/01.ANE.0000094985.19305.E9","article-title":"Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?","volume":"98","author":"Kopman","year":"2004","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.jclinane.2020.109818_bb0230","first-page":"18","article-title":"Comparative study of the residual neuromuscular blockade between pancuronium, vecuronium and rocuronium using train of four","volume":"36","author":"Swaro","year":"2016","journal-title":"Int J Pharm Sci Rev Res"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818020300362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818020300362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:14:14Z","timestamp":1760606054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818020300362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":46,"alternative-id":["S0952818020300362"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2020.109818","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2020.109818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109818"}}